Search
for
Sort by
Research 571–600 of 1000+
- COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- COVID-19 clinical outcomes and nationality: results from a Nationwide registry in Kuwait
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- COVID-19 and hypopituitarism
- A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19
- Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
- Characteristics of hair loss after COVID‐19: A systematic scoping review
- COVID-19 infection leading to acute pustular dermatoses
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- COVID-19 in Africa: an ovarian victory?
- COVID-19: The experience from Iran
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- COVID-19 pandemic: what about the gonads?
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Alopecia areata following COVID-19 vaccine: a systematic review
- Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Recovery From Alopecia After COVID-19
- COVID-19 Infection: Impact on Hair
- COVID-19: Evaluation and Care of Patients With Persistent Symptoms Following Acute SARS-CoV-2 Infection
- Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial
- Impact of the COVID‐19 pandemic on inpatient dermatology: a multicentre study from Hubei, China
- Race, ethnicity, and comorbidities are critical factors in the diagnosis of telogen effluvium during the COVID-19 pandemic
- COVID-19 Severity and Androgen Receptor Polymorphism
- Association between alopecia areata and COVID-19: A systematic review
- Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
- Characteristics of telogen effluvium in COVID-19 in western Iran (2020)